Abstract: The present invention relates to nucleoside derivatives represented by general formulas I and II, their synthetic methods and their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.
Type:
Grant
Filed:
April 1, 2005
Date of Patent:
July 29, 2008
Assignee:
Rexahn Corporation
Inventors:
Young Bok Lee, Chang Ho Ahn, Won Jun Choi, Lak Shin Jeong, Sang Kook Lee
Abstract: New antisense oligonucleotide compounds, RX-0047 and RX-0149, inhibit expression of HIF-1 and also induce cytotoxicity in several cancer cell lines.
Type:
Grant
Filed:
January 28, 2004
Date of Patent:
April 17, 2007
Assignee:
Rexahn Corporation
Inventors:
Heejeong Yoon, Lingjun Mao, Young Bok Lee, Chang-Ho Ahn, Xiaoming Jiang
Abstract: The present invention relates to nucleoside derivatives represented by general formulas I and II, their synthetic methods and their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.
Type:
Application
Filed:
April 1, 2005
Publication date:
October 6, 2005
Applicant:
Rexahn Corporation
Inventors:
Chang Ahn, Won Choi, Young Lee, Lak Jeong, Sang Lee